{"url_path":"/sec/bicx/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1443863/0001477932-26-003159-index.html","accession_number":"0001477932-26-003159","cik":"0001443863","ticker":"BICX","issuer_name":"BioCorRx Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1443863/0001477932-26-003159-index.html","primary_entity_key":"0001443863","primary_entity_name":"BioCorRx Inc."},"word_count":918,"has_tables":true,"body_markdown":"bicx_10q.htm\n0001443863false--12-31Q12026Common Stock, $0.001 par value006000000.0017500000002890655980000160000800001600008000080000160000160000falsefalsefalsefalse000000261037642021-09-092022-10-062023-01-252023-11-102023-12-082024-03-140000214802000001000002000002750001.500.7512329616400006125000001153340.10.11500163610687115334600000800008000080000160000160000160000100000100000400008879010.35700000200000200000000.2420.3519800091153192640000040000000014438632026-01-012026-03-310001443863us-gaap:SubsequentEventMember2026-04-012026-04-020001443863bicx:BoardOfDirectorsMemberus-gaap:SubsequentEventMember2026-05-012026-05-150001443863bicx:BICXHoldingCompanyLLCMember2026-03-310001443863bicx:BICXHoldingCompanyLLCMember2019-09-300001443863bicx:BICXHoldingCompanyLLCMember2026-01-012026-03-310001443863bicx:AlpineCreekMember2026-01-012026-03-310001443863bicx:AlpineCreekMember2015-12-100001443863bicx:AlpineCreekMember2025-12-310001443863bicx:AlpineCreekMember2026-03-310001443863bicx:CharlesRiverLaboratoriesIncMember2026-03-310001443863srt:BoardOfDirectorsChairmanMember2025-03-040001443863srt:BoardOfDirectorsChairmanMember2024-01-050001443863bicx:PellecomeMember2026-03-310001443863bicx:PellecomeMemberbicx:JanuaryFiveTwentyTwentyFourMember2026-03-310001443863bicx:PellecomeMember2025-03-110001443863bicx:PellecomeMember2023-10-012023-10-040001443863bicx:PellecomeMemberbicx:JanuaryFiveTwentyTwentyFourMember2026-01-012026-03-310001443863bicx:PellecomeMember2023-02-012023-02-020001443863bicx:PellecomeMember2026-01-012026-03-310001443863bicx:OrangeCountyResearchCenterMember2026-01-012026-03-310001443863bicx:ConsultantMember2026-03-310001443863bicx:ConsultantMember2026-01-012026-03-310001443863bicx:JosephDeSantoMDMember2020-10-012020-10-310001443863bicx:JosephDeSantoMDMember2026-01-012026-03-310001443863bicx:JosephDeSantoMDMember2025-01-012025-03-310001443863bicx:BioCorRxPharmaceuticalsIncMember2025-01-012025-03-310001443863us-gaap:SalesRevenueNetMemberbicx:TwoCustomersMember2025-01-012025-03-310001443863us-gaap:SalesRevenueNetMemberbicx:TwoCustomersMember2026-01-012026-03-310001443863us-gaap:AccountsReceivableMemberbicx:TwoCustomersMember2026-03-310001443863us-gaap:AccountsReceivableMemberbicx:TwoCustomersMember2025-12-310001443863bicx:BioCorRxPharmaceuticalsMember2016-07-280001443863bicx:BioCorRxIncMember2026-03-260001443863srt:DirectorMember2025-12-310001443863srt:DirectorMember2026-03-310001443863bicx:BioCorRxIncMember2026-03-012026-03-260001443863bicx:TwentyTwentyFiveQFourSPAMember2025-11-012025-11-200001443863bicx:TwentyTwentyFiveQFourSubscriptionAgreementMember2025-10-012025-10-210001443863bicx:TwentyTwentyFiveQFourSPAMember2025-11-200001443863bicx:QFourExchangeAgreementMember2026-03-310001443863bicx:QFourExchangeAgreementMember2025-10-012025-10-210001443863bicx:QFourExchangeAgreementMember2025-10-210001443863bicx:TwentyTwentyFiveQFourSubscriptionAgreementMember2025-10-210001443863bicx:WarrantsMember2024-03-012024-03-140001443863bicx:WarrantsMemberbicx:BottomMemberbicx:ThirdPartiesMember2023-11-012023-11-100001443863bicx:WarrantsMemberbicx:BottomMemberbicx:ThirdPartiesMember2023-12-012023-12-080001443863bicx:WarrantsMemberbicx:BottomMemberbicx:ThirdPartiesMember2026-01-012026-03-310001443863bicx:WarrantsMemberbicx:TopMemberbicx:ThirdPartiesMember2023-11-012023-11-100001443863bicx:WarrantsMemberbicx:TopMemberbicx:ThirdPartiesMember2023-12-012023-12-080001443863bicx:WarrantsMemberbicx:TopMemberbicx:ThirdPartiesMember2026-01-012026-03-310001443863bicx:TwoThousandTwentyTwoEquityIncentivePlanMember2026-01-012026-03-310001443863bicx:EquityIncentivePlan2018Member2026-01-012026-03-310001443863bicx:AlphaMember2025-11-012025-11-140001443863bicx:AlphaMember2025-07-012025-07-290001443863bicx:EquityIncentivePlan2016Member2026-01-012026-03-310001443863bicx:EquityIncentivePlan2014Member2026-01-012026-03-310001443863bicx:WarrantsMemberbicx:ThirdPartiesMember2023-11-012023-11-100001443863bicx:WarrantsMemberbicx:ThirdPartiesMember2023-12-012023-12-080001443863bicx:WarrantsMemberbicx:ThirdPartiesMember2025-02-012025-02-130001443863bicx:WarrantsMemberbicx:ThirdPartiesMember2024-10-012024-10-140001443863bicx:WarrantsMemberbicx:ThirdPartiesMember2024-11-012024-11-2900014438632025-07-012025-07-2900014438632024-03-012024-03-1400014438632025-07-290001443863bicx:AlphaMember2025-11-140001443863bicx:AlphaMember2025-07-290001443863bicx:WarrantsMember2026-03-310001443863bicx:WarrantsMember2026-01-012026-03-310001443863bicx:WarrantsMember2025-12-310001443863bicx:WarrantsOutstandingMember2026-03-310001443863bicx:WarrantsOutstandingMemberbicx:ExercisePriceZeroPointSixSevenMember2026-03-310001443863bicx:WarrantsExercisableMember2026-03-310001443863bicx:WarrantsExercisableMemberbicx:ExercisePriceZeroPointSixSevenMember2026-03-310001443863bicx:WarrantsExercisableMember2026-01-012026-03-310001443863bicx:WarrantsOutstandingMember2026-01-012026-03-310001443863bicx:WarrantsExercisableMemberbicx:ExercisePriceZeroPointSixSevenMember2026-01-012026-03-310001443863bicx:WarrantsOutstandingMemberbicx:ExercisePriceZeroPointSixSevenMember2026-01-012026-03-310001443863bicx:OptionOutstandingMember2026-03-310001443863bicx:OptionOutstandingMemberbicx:ExercisePriceThreeMember2026-03-310001443863bicx:OptionOutstandingMemberbicx:ExercisePriceTwoMember2026-03-310001443863bicx:OptionOutstandingMemberbicx:ExercisePriceOneMember2026-03-310001443863bicx:OptionExercisableMember2026-01-012026-03-310001443863bicx:OptionOutstandingMember2026-01-012026-03-310001443863bicx:OptionExercisableMemberbicx:ExercisePriceThreeMember2026-01-012026-03-310001443863bicx:OptionOutstandingMemberbicx:ExercisePriceThreeMember2026-01-012026-03-310001443863bicx:OptionExercisableMemberbicx:ExercisePriceTwoMember2026-01-012026-03-310001443863bicx:OptionOutstandingMemberbicx:ExercisePriceTwoMember2026-01-012026-03-310001443863bicx:OptionExercisableMemberbicx:ExercisePriceOneMember2026-01-012026-03-310001443863bicx:OptionOutstandingMemberbicx:ExercisePriceOneMember2026-01-012026-03-310001443863bicx:OptionExercisableMember2026-03-310001443863bicx:OptionExercisableMemberbicx:ExercisePriceThreeMember2026-03-310001443863bicx:OptionExercisableMemberbicx:ExercisePriceTwoMember2026-03-310001443863bicx:OptionExercisableMemberbicx:ExercisePriceOneMember2026-03-3100014438632023-09-300001443863us-gaap:RelatedPartyMember2025-01-012025-03-310001443863us-gaap:RelatedPartyMember2025-03-310001443863bicx:TwoThousandTwentySixQOneLucidoSubscriptionAgreementMember2026-03-310001443863bicx:TwoThousandTwentySixQOneLucidoSubscriptionAgreementMember2026-01-012026-03-310001443863bicx:WarrantsMember2025-01-012025-03-310001443863us-gaap:AccountsPayableMember2025-03-310001443863bicx:CommonStocksMember2026-01-012026-03-310001443863us-gaap:AccountsPayableMember2025-01-012025-03-310001443863bicx:CommonStocksMember2025-01-012025-03-310001443863bicx:ConvertiblePromissoryNotesMember2025-01-012025-03-310001443863bicx:ConvertiblePromissoryNotesMember2026-01-012026-03-310001443863bicx:BoardOfDirectorsMember2026-01-012026-03-310001443863bicx:BoardOfDirectorsMember2025-01-012025-03-310001443863bicx:SeriesBConvertiblePreferredStockMember2026-01-012026-03-310001443863bicx:SeriesAConvertiblePreferredStockMember2026-01-012026-03-310001443863bicx:JosephGalliganMemberbicx:TopMember2026-01-012026-03-310001443863bicx:JosephGalliganMemberbicx:BottomMember2026-01-012026-03-310001443863bicx:AprilTwentyEightTwoThousandTwentyMemberMember2026-01-012026-03-310001443863bicx:EconomicInjuryDisasterLoanAssistanceProgramMember2025-01-012025-03-310001443863bicx:EconomicInjuryDisasterLoanAssistanceProgramMember2026-01-012026-03-310001443863bicx:JulySeventeenTwoThousandTwentyMemberbicx:EconomicInjuryDisasterLoanAssistanceProgramMember2025-01-012025-03-310001443863bicx:JulySeventeenTwoThousandTwentyMemberbicx:EconomicInjuryDisasterLoanAssistanceProgramMember2026-01-012026-03-310001443863bicx:LourdesFelixMember2025-01-012025-03-310001443863bicx:LourdesFelixMember2026-01-012026-03-310001443863bicx:TwoThousandTwentySixMemberbicx:LouisLucidoMember2025-01-012025-03-310001443863bicx:TwoThousandTwentySixMemberbicx:LouisLucidoMember2026-01-012026-03-310001443863bicx:KentEmryMember2013-01-032013-01-220001443863bicx:TwoThousandTwentySixMemberbicx:LouisLucidoMember2026-02-012026-02-150001443863bicx:TwoThousandTwentySixMemberbicx:LouisLucidoMember2026-02-150001443863bicx:TwoThousandTwentySixMemberbicx:LouisLucidoMember2025-12-310001443863bicx:TwoThousandTwentySixMemberbicx:LouisLucidoMember2026-03-310001443863bicx:LourdesFelixMember2025-12-310001443863bicx:LourdesFelixMember2026-03-310001443863bicx:LouisCLucidoMember2025-12-310001443863bicx:LouisCLucidoMember2026-03-310001443863bicx:KentEmryMember2025-12-310001443863bicx:KentEmryMember2026-03-310001443863bicx:JanuaryTwentyFivewoThousandTwentyThreeMemberbicx:ThirdPartyMember2026-03-310001443863bicx:JanuaryTwentyFivewoThousandTwentyThreeMemberbicx:ThirdPartyMember2025-12-310001443863bicx:JanuaryTwentyFivewoThousandTwentyThreeMemberbicx:ThirdPartyMember2023-01-250001443863bicx:OctoberSixTwoThousandTwentyOneMemberbicx:ThirdPartyMember2022-10-060001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2025-12-310001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2026-03-310001443863bicx:DecemberEightTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2024-08-012024-08-230001443863bicx:JanuaryTwentyFivewoThousandTwentyThreeMemberbicx:ThirdPartyMember2026-01-012026-03-310001443863bicx:JanuaryTwentyFivewoThousandTwentyThreeMemberbicx:ThirdPartyMember2025-01-012025-03-310001443863bicx:OctoberSixTwoThousandTwentyOneMemberbicx:ThirdPartyMember2026-01-012026-03-310001443863bicx:OctoberSixTwoThousandTwentyOneMemberbicx:ThirdPartyMember2025-01-012025-03-310001443863bicx:SeptemberNineTwoThousandTwentyOneMemberbicx:ThirdPartyMember2026-01-012026-03-310001443863bicx:SeptemberNineTwoThousandTwentyOneMemberbicx:ThirdPartyMember2025-01-012025-03-310001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2024-10-140001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2024-07-110001443863bicx:DecemberEightTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2024-11-290001443863bicx:DecemberEightTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2025-12-310001443863bicx:DecemberEightTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2026-03-310001443863bicx:DecemberEightTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2024-03-250001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2025-12-310001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2026-03-310001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2024-10-140001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2024-07-110001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2026-03-130001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2025-02-280001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2025-02-012025-02-280001443863bicx:DecemberEightTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2025-04-012025-04-070001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2026-03-012026-03-130001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2024-12-012024-12-310001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2024-07-012024-07-110001443863bicx:DecemberEightTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2025-01-012025-01-310001443863bicx:DecemberEightTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2024-03-012024-03-250001443863bicx:DecemberEightTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2024-11-012024-11-290001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2024-12-012024-12-310001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2024-10-012024-10-140001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2024-03-012024-03-080001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2026-03-012026-03-130001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2024-10-012024-10-140001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2024-07-012024-07-110001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2025-02-012025-02-280001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2026-03-130001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2025-02-280001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2024-03-140001443863bicx:DecemberEightTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2025-04-070001443863bicx:DecemberEightTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2023-12-080001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2023-11-100001443863bicx:OctoberSixTwoThousandTwentyOneMemberbicx:ThirdPartyMember2026-03-310001443863bicx:OctoberSixTwoThousandTwentyOneMemberbicx:ThirdPartyMember2025-12-310001443863bicx:SeptemberNineTwoThousandTwentyOneMemberbicx:ThirdPartyMember2026-03-310001443863bicx:SeptemberNineTwoThousandTwentyOneMemberbicx:ThirdPartyMember2025-12-310001443863bicx:SeptemberNineTwoThousandTwentyOneMemberbicx:ThirdPartyMember2021-09-090001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2024-03-012024-03-140001443863bicx:DecemberEightTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2023-12-012023-12-080001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2025-01-012025-03-310001443863bicx:MarchFourteenTwoThousandTwentyFourMemberbicx:ThirdPartyMember2026-01-012026-03-310001443863bicx:DecemberEightTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2025-01-012025-03-310001443863bicx:DecemberEightTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2026-01-012026-03-310001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2025-01-012025-03-310001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2023-11-012023-11-100001443863bicx:SeptemberTenTwoThousandTwentyThreeMemberbicx:ThirdPartyMember2026-01-012026-03-310001443863bicx:JanuaryTwentyFivewoThousandTwentyThreeMemberbicx:ThirdPartyMember2023-01-012023-01-250001443863bicx:OctoberSixTwoThousandTwentyOneMemberbicx:ThirdPartyMember2022-10-012022-10-060001443863bicx:SeptemberNineTwoThousandTwentyOneMemberbicx:ThirdPartyMember2021-09-012021-09-090001443863bicx:PromissoryNotePayableSixMember2025-12-310001443863bicx:PromissoryNotePayableFiveMember2025-12-310001443863bicx:PromissoryNotePayableFourMember2025-12-310001443863bicx:PromissoryNotePayableThreeMember2025-12-310001443863bicx:PromissoryNotePayableTwoMember2025-12-310001443863bicx:PromissoryNotePayableOneMember2025-12-310001443863bicx:AdvancesFromThirdPartyMember2025-12-310001443863bicx:PromissoryNotePayableSixMember2026-01-012026-03-310001443863bicx:PromissoryNotePayableFiveMember2026-01-012026-03-310001443863bicx:PromissoryNotePayableFourMember2026-01-012026-03-310001443863bicx:PromissoryNotePayableThreeMember2026-01-012026-03-310001443863bicx:PromissoryNotePayableTwoMember2026-01-012026-03-310001443863bicx:PromissoryNotePayableOneMember2026-01-012026-03-310001443863bicx:PromissoryNotePayableSixMember2026-03-310001443863bicx:PromissoryNotePayableFiveMember2026-03-310001443863bicx:PromissoryNotePayableFourMember2026-03-310001443863bicx:PromissoryNotePayableThreeMember2026-03-310001443863bicx:PromissoryNotePayableTwoMember2026-03-310001443863bicx:PromissoryNotePayableOneMember2026-03-310001443863bicx:AdvancesFromThirdPartyMember2026-03-310001443863us-gaap:IntellectualPropertyMember2026-03-310001443863us-gaap:IntellectualPropertyMember2026-01-012026-03-310001443863us-gaap:IntellectualPropertyMember2025-01-012025-03-310001443863bicx:NaltrexoneImplantFormulationMemberbicx:NewZealandAndAustraliaFromTrinityCompoundSolutionsMember2018-09-252018-10-120001443863us-gaap:CustomerListsMember2025-01-012025-03-310001443863bicx:CustomerBaseMember2025-12-310001443863bicx:CustomerBaseMember2026-03-310001443863us-gaap:TrademarksMember2025-12-310001443863us-gaap:PatentsMember2025-12-310001443863us-gaap:PatentsMember2026-03-310001443863bicx:LeaseAgreementMemberbicx:TopMember2026-01-012026-03-310001443863bicx:BottomMemberbicx:LeaseAgreementMember2026-01-012026-03-3100014438632024-04-012024-04-0900014438632025-03-0400014438632025-03-012025-03-040001443863us-gaap:CustomerListsMember2026-03-310001443863us-gaap:TrademarksMember2026-03-310001443863us-gaap:TrademarksMember2026-01-012026-03-310001443863us-gaap:CustomerListsMember2026-01-012026-03-310001443863bicx:BioCorRxPharmaceuticalsIncMember2026-01-012026-03-310001443863bicx:UnsecuredPromissoryNoteMember2023-12-012023-12-080001443863bicx:UnsecuredPromissoryNoteMember2026-01-012026-03-310001443863bicx:UnsecuredPromissoryNoteMember2026-03-012026-03-130001443863bicx:FebruaryTwentyTwoTwoThousandTwentyFourMember2026-01-012026-03-310001443863bicx:MrLucidoMember2026-01-012026-03-310001443863bicx:MrLucidoMember2026-03-310001443863bicx:TwoThousandTwentySixQOneLucidoSubscriptionAgreementMember2026-02-150001443863bicx:TwoThousandTwentySixQOneLucidoSubscriptionAgreementMember2026-02-012026-02-150001443863bicx:TopMember2026-01-012026-03-310001443863bicx:BottomMember2026-01-012026-03-3100014438632025-01-012025-12-3100014438632019-01-1700014438632024-03-010001443863bicx:BioCorRxPharmaceuticalsIncMember2016-07-012016-07-280001443863bicx:BioCorRxPharmaceuticalsIncMember2016-07-280001443863us-gaap:NoncontrollingInterestMember2026-03-310001443863us-gaap:RetainedEarningsMember2026-03-310001443863us-gaap:AdditionalPaidInCapitalMember2026-03-310001443863bicx:CommonStockSubscribedMember2026-03-310001443863us-gaap:CommonStockMember2026-03-310001443863bicx:SeriesBPreferredStocksMember2026-03-310001443863bicx:SeriesAPreferredStocksMember2026-03-310001443863us-gaap:NoncontrollingInterestMember2026-01-012026-03-310001443863us-gaap:RetainedEarningsMember2026-01-012026-03-310001443863us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-310001443863bicx:CommonStockSubscribedMember2026-01-012026-03-310001443863us-gaap:CommonStockMember2026-01-012026-03-310001443863bicx:SeriesBPreferredStocksMember2026-01-012026-03-310001443863bicx:SeriesAPreferredStocksMember2026-01-012026-03-310001443863us-gaap:NoncontrollingInterestMember2025-12-310001443863us-gaap:RetainedEarningsMember2025-12-310001443863us-gaap:AdditionalPaidInCapitalMember2025-12-310001443863bicx:CommonStockSubscribedMember2025-12-310001443863us-gaap:CommonStockMember2025-12-310001443863bicx:SeriesBPreferredStocksMember2025-12-310001443863bicx:SeriesAPreferredStocksMember2025-12-3100014438632025-03-310001443863us-gaap:NoncontrollingInterestMember2025-03-310001443863us-gaap:RetainedEarningsMember2025-03-310001443863us-gaap:AdditionalPaidInCapitalMember2025-03-310001443863bicx:CommonStockSubscribedMember2025-03-310001443863us-gaap:CommonStockMember2025-03-310001443863bicx:SeriesBPreferredStocksMember2025-03-310001443863bicx:SeriesAPreferredStocksMember2025-03-310001443863us-gaap:NoncontrollingInterestMember2025-01-012025-03-310001443863us-gaap:RetainedEarningsMember2025-01-012025-03-310001443863us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001443863bicx:CommonStockSubscribedMember2025-01-012025-03-310001443863us-gaap:CommonStockMember2025-01-012025-03-310001443863bicx:SeriesBPreferredStocksMember2025-01-012025-03-310001443863bicx:SeriesAPreferredStocksMember2025-01-012025-03-3100014438632024-12-310001443863us-gaap:NoncontrollingInterestMember2024-12-310001443863us-gaap:RetainedEarningsMember2024-12-310001443863us-gaap:AdditionalPaidInCapitalMember2024-12-310001443863bicx:CommonStockSubscribedMember2024-12-310001443863us-gaap:CommonStockMember2024-12-310001443863bicx:SeriesBPreferredStocksMember2024-12-310001443863bicx:SeriesAPreferredStocksMember2024-12-3100014438632025-01-012025-03-310001443863bicx:SerieBConvertiblePreferredStockMember2025-12-310001443863bicx:SerieAConvertiblePreferredStockMember2026-03-310001443863bicx:SerieBConvertiblePreferredStockMember2026-03-310001443863bicx:SerieAConvertiblePreferredStockMember2025-12-310001443863bicx:SeriesBConvertiblePreferredStockMember2025-12-310001443863bicx:SeriesBConvertiblePreferredStockMember2026-03-310001443863bicx:SeriesAConvertiblePreferredStockMember2025-12-310001443863bicx:SeriesAConvertiblePreferredStockMember2026-03-3100014438632025-12-3100014438632026-03-3100014438632026-05-14iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:pure\n\n \n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n \n\n**FORM 10-Q**\n\n \n\n(Mark One)\n\n \n\n☒\n\nQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\n \n\nFor the quarterly period ended **March 31, 2026**\n\n \n\n☐\n\nTRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934\n\n \n\nFor the transition period from ____________ to ___________\n\n \n\nCommission file number:** 000-54208**\n\n \n\n**BioCorRx Inc.**\n\n(Exact name of registrant as specified in its charter)\n\n \n\n**Nevada**\n\n \n\n**90-0967447**\n\n(State or other jurisdiction of\n\nincorporation or organization)\n\n \n\n(IRS Employer\n\nIdentification No.)\n\n \n\n \n\n \n\n**2390 East Orangewood Avenue, Suite 570**\n\n**Anaheim, CA**\n\n \n\n**92806**\n\n(Address of principal executive offices)\n\n \n\n(Zip Code)\n\n \n\n**(714) 462-4880**\n\n(Registrant’s telephone number, including area code)\n\n \n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n \n\n**Title of each class**\n\n \n\n**Trading Symbol(s)**\n\n \n\n**Name of each exchange**\n\n**on which registered**\n\nN/A\n\n \n\nN/A\n\n \n\nN/A\n\n \n\nIndicate by check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒     No ☐\n\n \n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒     No ☐\n\n \n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer\n\n☐\n\nAccelerated filer\n\n☐\n\nNon-accelerated Filer\n\n☒\n\nSmaller reporting company\n\n☒\n\nEmerging growth company\n\n☐\n\n \n\n \n\n \n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐\n\n \n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐     No ☒\n\n \n\nAs of May 14, 2026, there were 29,055,547 shares of registrant’s common stock outstanding.\n\n \n\n \n\n \n\n \n\nTABLE OF CONTENTS\n\n \n\n[PART I. FINANCIAL INFORMATION](#p1)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n[ITEM 1.](#i1)\n\n[Financial Statements (Unaudited)](#i1)\n\n \n\n4\n\n \n\n \n\n[Condensed Consolidated Balance Sheets as of March 31, 2026 (unaudited) and December 31, 2025](#bs)\n\n \n\n4\n\n \n\n \n\n[Condensed Consolidated Statements of Operations for the three months ended March 31, 2026 and 2025 (unaudited)](#cso)\n\n \n\n5\n\n \n\n \n\n[Condensed Consolidated Statement of Deficit for the three months ended March 31, 2026 (unaudited)](#defict)\n\n \n\n6\n\n \n\n \n\n[Condensed Consolidated Statement of Deficit for the three months ended March 31, 2025 (unaudited)](#defict2)\n\n \n\n7\n\n \n\n \n\n[Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and 2025 (unaudited)](#cf)\n\n \n\n8\n\n \n\n \n\n[Notes to Condensed Consolidated Financial Statements](#notes)\n\n \n\n9\n\n \n\n[ITEM 2.](#i2)\n\n[Management’s Discussion and Analysis of Financial Condition and Results of Operations](#i2)\n\n \n\n38\n\n \n\n[ITEM 3.](#i3)\n\n[Quantitative and Qualitative Disclosures about Market Risk](#i3)\n\n \n\n45\n\n \n\n[ITEM 4.](#i4)\n\n[Controls and Procedures](#i4)\n\n \n\n45\n\n \n\n \n\n \n\n \n\n \n\n \n\n[PART II. OTHER INFORMATION](#p2)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n[ITEM 1.](#p2i1)\n\n[Legal Proceedings](#p2i1)\n\n \n\n46\n\n \n\n[ITEM 1A.](#p2i1a)\n\n[Risk Factors](#p2i1a)\n\n \n\n46\n\n \n\n[ITEM 2.](#p2i2)\n\n[Unregistered Sales of Equity Securities and Use of Proceeds](#p2i2)\n\n \n\n46\n\n \n\n[ITEM 3.](#p2i3)\n\n[Defaults Upon Senior Securities](#p2i3)\n\n \n\n47\n\n \n\n[ITEM 4.](#p2i4)\n\n[Mine Safety Disclosures](#p2i4)\n\n \n\n47\n\n \n\n[ITEM 5.](#p2i5)\n\n[Other Information](#p2i5)\n\n \n\n47\n\n \n\n[ITEM 6.](#p2i6)\n\n[Exhibits](#p2i6)\n\n \n\n48\n\n \n\n \n\n \n\n \n\n \n\n \n\n[SIGNATURES](#sig)\n\n \n\n49\n\n \n\n \n\n \n\n2\n\n*Table of Contents*\n\n \n\nThis Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this Quarterly Report on Form 10-Q may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.\n\n \n\nUnless expressly indicated or the context requires otherwise, the terms “BioCorRx,” “Company,” “we,” “us,” and “our” in this document refer to BioCorRx Inc., a Nevada corporation, and, where appropriate, its wholly owned subsidiaries.\n\n \n\n \n\n3\n\n*Table of Contents*\n\n \n\nPART I - FINANCIAL INFORMATION"}